TermID Term Enrichment logP Genes in Term Target Genes in Term Fraction of Targets in Term Total Target Genes Total Genes Entrez Gene IDs Gene Symbols WP23 B Cell Receptor Signaling Pathway 0.000421262332719599 -7.77225480024056 98 4 0.2 20 5310 5788,2549,5777,6850 PTPRC,GAB1,PTPN6,SYK WP286 IL-3 Signaling Pathway 0.00075398308240547 -7.19014062733606 49 3 0.15 20 5310 5777,3055,6850 PTPN6,HCK,SYK WP2509 Nanoparticle triggered autophagic cell death 0.00353992057616261 -5.6436509882004 24 2 0.1 20 5310 81671,22863 VMP1,ATG14 WP364 IL-6 signaling pathway 0.0110963773410704 -4.50113658960205 43 2 0.1 20 5310 3055,2549 HCK,GAB1 WP2853 Endoderm Differentiation 0.0161725595739289 -4.12443932639678 145 3 0.15 20 5310 1601,10973,10451 DAB2,ASCC3,VAV3 WP585 Interferon type I signaling pathways 0.01776258578757 -4.03066095586925 55 2 0.1 20 5310 5788,5777 PTPRC,PTPN6 WP3863 T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection 0.0222663214423744 -3.80467999131282 62 2 0.1 20 5310 5777,5788 PTPN6,PTPRC WP69 T-Cell antigen Receptor (TCR) Signaling Pathway 0.045188463390332 -3.09691345944905 91 2 0.1 20 5310 10451,10019 VAV3,SH2B3 WP12 Osteoclast Signaling 0.058671437342661 -2.83580225757744 16 1 0.05 20 5310 6548 SLC9A1 WP247 Small Ligand GPCRs 0.0693018116169307 -2.66928423146951 19 1 0.05 20 5310 5739 PTGIR WP357 Fatty Acid Biosynthesis 0.0798180755541345 -2.52800528947261 22 1 0.05 20 5310 32 ACACB WP581 EPO Receptor Signaling 0.0936642610479377 -2.36803858140854 26 1 0.05 20 5310 5788 PTPRC WP2035 Follicle Stimulating Hormone (FSH) signaling pathway 0.097094752110492 -2.33206795138133 27 1 0.05 20 5310 2870 GRK6 WP2380 Brain-Derived Neurotrophic Factor (BDNF) signaling pathway 0.100994252113123 -2.29269167353136 144 2 0.1 20 5310 10451,32 VAV3,ACACB WP1449 Regulation of toll-like receptor signaling pathway 0.102180569491279 -2.28101374168261 145 2 0.1 20 5310 6850,5777 SYK,PTPN6 WP2583 T-Cell Receptor and Co-stimulatory Signaling 0.103918763601534 -2.26414580428935 29 1 0.05 20 5310 5777 PTPN6 WP3844 PI3K-AKT-mTOR signaling pathway and therapeutic opportunities 0.107312367981248 -2.23201137055236 30 1 0.05 20 5310 7942 TFEB WP98 Prostaglandin Synthesis and Regulation 0.107312367981248 -2.23201137055236 30 1 0.05 20 5310 5739 PTGIR WP2857 Mesodermal Commitment Pathway 0.114260765759182 -2.16927202380751 155 2 0.1 20 5310 10973,10451 ASCC3,VAV3 WP2197 Endothelin Pathways 0.11742007653897 -2.14199737650701 33 1 0.05 20 5310 5739 PTGIR WP3676 BDNF-TrkB Signaling 0.11742007653897 -2.14199737650701 33 1 0.05 20 5310 2549 GAB1 WP313 Signaling of Hepatocyte Growth Factor Receptor 0.120765082881578 -2.11390808425769 34 1 0.05 20 5310 2549 GAB1 WP437 EGF/EGFR Signaling Pathway 0.122936616651334 -2.09608636820624 162 2 0.1 20 5310 2549,10451 GAB1,VAV3 WP244 Alpha 6 Beta 4 signaling pathway 0.124098043142794 -2.08668335528595 35 1 0.05 20 5310 2549 GAB1 WP500 Glycogen Metabolism 0.127418998429217 -2.06027442271382 36 1 0.05 20 5310 5257 PHKB WP127 IL-5 Signaling Pathway 0.140583587296005 -1.96195303973377 40 1 0.05 20 5310 6850 SYK WP49 IL-2 Signaling Pathway 0.147094910908719 -1.916677248107 42 1 0.05 20 5310 6850 SYK WP2203 Thymic Stromal LymphoPoietin (TSLP) Signaling Pathway 0.163168802442989 -1.81297001622711 47 1 0.05 20 5310 3055 HCK WP2864 Apoptosis-related network due to altered Notch3 in ovarian cancer 0.185189417755764 -1.68637609795029 54 1 0.05 20 5310 10451 VAV3 WP673 ErbB Signaling Pathway 0.185189417755764 -1.68637609795029 54 1 0.05 20 5310 2549 GAB1 WP2018 RANKL/RANK (Receptor activator of NFKB (ligand)) Signaling Pathway 0.188289914643272 -1.66977240479977 55 1 0.05 20 5310 6850 SYK WP395 IL-4 Signaling Pathway 0.188289914643272 -1.66977240479977 55 1 0.05 20 5310 5777 PTPN6 WP304 Kit receptor signaling pathway 0.203625012790449 -1.59147514924618 60 1 0.05 20 5310 5777 PTPN6 WP3584 MECP2 and Associated Rett Syndrome 0.209681650152976 -1.56216485013446 62 1 0.05 20 5310 4354 MPP1 WP1403 AMP-activated Protein Kinase (AMPK) Signaling 0.227590104746419 -1.48020905418467 68 1 0.05 20 5310 32 ACACB WP428 Wnt Signaling Pathway 0.233473430199017 -1.45468699764525 70 1 0.05 20 5310 83999 KREMEN1 WP2037 Prolactin Signaling Pathway 0.250869045479691 -1.38282420715602 76 1 0.05 20 5310 5777 PTPN6 WP2034 Leptin signaling pathway 0.250869045479691 -1.38282420715602 76 1 0.05 20 5310 32 ACACB WP2261 Signaling Pathways in Glioblastoma 0.270689925214967 -1.30678130058322 83 1 0.05 20 5310 2549 GAB1 WP2355 Corticotropin-releasing hormone signaling pathway 0.298143041153436 -1.21018190377115 93 1 0.05 20 5310 2870 GRK6 WP35 G Protein Signaling Pathways 0.303514547028201 -1.19232573873107 95 1 0.05 20 5310 6548 SLC9A1 WP185 Integrin-mediated Cell Adhesion 0.324612563880951 -1.12512291891763 103 1 0.05 20 5310 10451 VAV3 WP615 Senescence and Autophagy in Cancer 0.332366649070212 -1.1015165547584 106 1 0.05 20 5310 22863 ATG14 WP366 TGF-beta Signaling Pathway 0.398448711895285 -0.92017649193245 133 1 0.05 20 5310 1601 DAB2 WP2858 Ectoderm Differentiation 0.42130774893049 -0.864391717262232 143 1 0.05 20 5310 8495 PPFIBP2 WP2059 Alzheimers Disease 0.432425425024887 -0.838345395165689 148 1 0.05 20 5310 81671 VMP1 WP51 Regulation of Actin Cytoskeleton 0.43462447414012 -0.833272898571163 149 1 0.05 20 5310 6548 SLC9A1 WP536 Calcium Regulation in the Cardiac Cell 0.438998313485697 -0.823259707632576 151 1 0.05 20 5310 2870 GRK6 WP289 Myometrial Relaxation and Contraction Pathways 0.454054978823095 -0.789536989543364 158 1 0.05 20 5310 2870 GRK6 WP481 Insulin Signaling 0.460389609167637 -0.775682171529762 161 1 0.05 20 5310 2549 GAB1 WP306 Focal Adhesion 0.527471036567036 -0.639661322121282 195 1 0.05 20 5310 3055 HCK WP455 GPCRs, Class A Rhodopsin-like 0.632837674469971 -0.457541328159983 259 1 0.05 20 5310 5739 PTGIR WP2881 Estrogen Receptor Pathway 0.999999999987513 -1.24870975780317e-11 13 0 0 20 5310 WP1991 SRF and miRs in Smooth Muscle Differentiation and Proliferation 0.999999999987513 -1.24870975780317e-11 13 0 0 20 5310 WP1423 Ganglio Sphingolipid Metabolism 0.999999999987513 -1.24870975780317e-11 13 0 0 20 5310 WP1434 Osteopontin Signaling 0.999999999987513 -1.24870975780317e-11 13 0 0 20 5310 WP3876 BMP2-WNT4-FOXO1 Pathway in Human Primary Endometrial Stromal Cell Differentiation 0.999999999987513 -1.24870975780317e-11 13 0 0 20 5310 WP3871 Valproic acid pathway 0.999999999987513 -1.24870975780317e-11 13 0 0 20 5310 WP186 Homologous recombination 0.999999999987513 -1.24870975780317e-11 13 0 0 20 5310 WP3892 Development of pulmonary dendritic cells and macrophage subsets 0.999999999987513 -1.24870975780317e-11 13 0 0 20 5310 WP3679 Cell-type Dependent Selectivity of CCK2R Signaling 0.999999999987513 -1.24870975780317e-11 13 0 0 20 5310 WP195 IL-1 signaling pathway 0.999999999988749 -1.12512984572977e-11 57 0 0 20 5310 WP2795 Cardiac Hypertrophic Response 0.999999999988749 -1.12512984572977e-11 57 0 0 20 5310 WP2369 Histone Modifications 0.999999999990504 -9.4960500491023e-12 69 0 0 20 5310 WP176 Folate Metabolism 0.999999999990504 -9.4960500491023e-12 69 0 0 20 5310 WP707 DNA Damage Response 0.999999999990504 -9.4960500491023e-12 69 0 0 20 5310 WP3298 Melatonin metabolism and effects 0.999999999990578 -9.42166616898292e-12 36 0 0 20 5310 WP2012 miRs in Muscle Cell Differentiation 0.999999999990578 -9.42166616898292e-12 36 0 0 20 5310 WP2029 Cell Differentiation - Index 0.999999999990601 -9.39861386978899e-12 38 0 0 20 5310 WP383 Striated Muscle Contraction 0.999999999990601 -9.39861386978899e-12 38 0 0 20 5310 WP2447 Amyotrophic lateral sclerosis (ALS) 0.999999999990601 -9.39861386978899e-12 38 0 0 20 5310 WP2526 PDGF Pathway 0.999999999990601 -9.39861386978899e-12 38 0 0 20 5310 WP22 IL-9 Signaling Pathway 0.999999999990804 -9.19582260460387e-12 19 0 0 20 5310 WP697 Estrogen metabolism 0.999999999990804 -9.19582260460387e-12 19 0 0 20 5310 WP1992 TarBasePathway 0.999999999990804 -9.19582260460387e-12 19 0 0 20 5310 WP734 Serotonin Receptor 4/6/7 and NR3C Signaling 0.999999999990804 -9.19582260460387e-12 19 0 0 20 5310 WP2011 SREBF and miR33 in cholesterol and lipid homeostasis 0.999999999990804 -9.19582260460387e-12 19 0 0 20 5310 WP2879 Farnesoid X Receptor Pathway 0.999999999990804 -9.19582260460387e-12 19 0 0 20 5310 WP404 Nucleotide Metabolism 0.999999999990804 -9.19582260460387e-12 19 0 0 20 5310 WP3287 Overview of nanoparticle effects 0.999999999990804 -9.19582260460387e-12 19 0 0 20 5310 WP384 Apoptosis Modulation by HSP70 0.999999999990804 -9.19582260460387e-12 19 0 0 20 5310 WP3877 Simplified Depiction of MYD88 Distinct Input-Output Pathway 0.999999999990804 -9.19582260460387e-12 19 0 0 20 5310 WP311 Synthesis and Degradation of Ketone Bodies 0.999999999991284 -8.71648699287134e-12 5 0 0 20 5310 WP688 Catalytic cycle of mammalian Flavin-containing MonoOxygenases (FMOs) 0.999999999991284 -8.71648699287134e-12 5 0 0 20 5310 WP2868 TCA Cycle Nutrient Utilization and Invasiveness of Ovarian Cancer 0.999999999991284 -8.71648699287134e-12 5 0 0 20 5310 WP3596 miR-517 relationship with ARCN1 and USP1 0.999999999991284 -8.71648699287134e-12 5 0 0 20 5310 WP2597 Secretion of Hydrochloric Acid in Parietal Cells 0.999999999991284 -8.71648699287134e-12 5 0 0 20 5310 WP2542 Sulindac Metabolic Pathway 0.999999999991284 -8.71648699287134e-12 5 0 0 20 5310 WP2328 Allograft Rejection 0.99999999999141 -8.5903048254328e-12 80 0 0 20 5310 WP2359 Parkin-Ubiquitin Proteasomal System pathway 0.999999999991471 -8.52930865194871e-12 70 0 0 20 5310 WP710 DNA Damage Response (only ATM dependent) 0.999999999992131 -7.86868316154387e-12 114 0 0 20 5310 WP732 Serotonin Receptor 2 and ELK-SRF/GATA4 signaling 0.999999999992294 -7.70552558355885e-12 20 0 0 20 5310 WP516 Hypertrophy Model 0.999999999992294 -7.70552558355885e-12 20 0 0 20 5310 WP1742 TP53 Network 0.999999999992294 -7.70552558355885e-12 20 0 0 20 5310 WP1422 Sphingolipid Metabolism 0.999999999992294 -7.70552558355885e-12 20 0 0 20 5310 WP391 Mitochondrial Gene Expression 0.999999999992294 -7.70552558355885e-12 20 0 0 20 5310 WP497 Urea cycle and metabolism of amino groups 0.999999999992294 -7.70552558355885e-12 20 0 0 20 5310 WP2846 Proprotein convertase subtilisin/kexin type 9 (PCSK9) mediated LDL receptor degradation 0.999999999992696 -7.30356845959546e-12 3 0 0 20 5310 WP3408 Evolocumab Mechanism 0.999999999992696 -7.30356845959546e-12 3 0 0 20 5310 WP2036 TNF related weak inducer of apoptosis (TWEAK) Signaling Pathway 0.999999999992856 -7.14410836975564e-12 42 0 0 20 5310 WP405 Eukaryotic Transcription Initiation 0.999999999992856 -7.14410836975564e-12 42 0 0 20 5310 WP2636 Common Pathways Underlying Drug Addiction 0.999999999992856 -7.14410836975564e-12 42 0 0 20 5310 WP466 DNA Replication 0.999999999992856 -7.14410836975564e-12 42 0 0 20 5310 WP560 TGF-beta Receptor Signaling 0.999999999994066 -5.93413318251635e-12 58 0 0 20 5310 WP1589 Folate-Alcohol and Cancer Pathway 0.999999999994118 -5.88176359072221e-12 8 0 0 20 5310 WP237 Glucocorticoid & Mineralcorticoid Metabolism 0.999999999994118 -5.88176359072221e-12 8 0 0 20 5310 WP3407 FTO Obesity Variant Mechanism 0.999999999994118 -5.88176359072221e-12 8 0 0 20 5310 WP2338 miRNA Biogenesis 0.999999999994118 -5.88176359072221e-12 8 0 0 20 5310 WP2485 NAD Biosynthesis II (from tryptophan) 0.999999999994118 -5.88176359072221e-12 8 0 0 20 5310 WP3635 Insulin signalling in human adipocytes (diabetic condition) 0.999999999994118 -5.88176359072221e-12 8 0 0 20 5310 WP1604 Codeine and Morphine Metabolism 0.999999999994118 -5.88176359072221e-12 8 0 0 20 5310 WP3655 Hypothetical Craniofacial Development Pathway 0.999999999994118 -5.88176359072221e-12 8 0 0 20 5310 WP2276 Glial Cell Differentiation 0.999999999994118 -5.88176359072221e-12 8 0 0 20 5310 WP136 Phase I biotransformations, non P450 0.999999999994118 -5.88176359072221e-12 8 0 0 20 5310 WP3634 Insulin signalling in human adipocytes (normal condition) 0.999999999994118 -5.88176359072221e-12 8 0 0 20 5310 WP698 Glucuronidation 0.999999999994367 -5.63303053070242e-12 26 0 0 20 5310 WP530 Cytokines and Inflammatory Response 0.999999999994367 -5.63303053070242e-12 26 0 0 20 5310 WP2878 PPAR Alpha Pathway 0.999999999994367 -5.63303053070242e-12 26 0 0 20 5310 WP26 Signal Transduction of S1P Receptor 0.999999999994367 -5.63303053070242e-12 26 0 0 20 5310 WP325 Triacylglyceride Synthesis 0.999999999994367 -5.63303053070242e-12 26 0 0 20 5310 WP138 Androgen receptor signaling pathway 0.999999999994383 -5.61655170230567e-12 90 0 0 20 5310 WP477 Cytoplasmic Ribosomal Proteins 0.999999999994383 -5.61655170230567e-12 90 0 0 20 5310 WP2272 Pathogenic Escherichia coli infection 0.999999999994618 -5.38198943139304e-12 55 0 0 20 5310 WP422 MAPK Cascade 0.999999999994623 -5.37666798942324e-12 29 0 0 20 5310 WP3613 Photodynamic therapy-induced unfolded protein response 0.999999999994623 -5.37666798942324e-12 29 0 0 20 5310 WP2643 Nanoparticle-mediated activation of receptor signaling 0.999999999994623 -5.37666798942324e-12 29 0 0 20 5310 WP3593 miR-148a/miR-31/FIH1/HIF1α-Notch signaling in glioblastoma 0.99999999999488 -5.12026694523093e-12 9 0 0 20 5310 WP531 Mismatch repair 0.99999999999488 -5.12026694523093e-12 9 0 0 20 5310 WP3875 ATR Signaling 0.99999999999488 -5.12026694523093e-12 9 0 0 20 5310 WP288 NLR Proteins 0.99999999999488 -5.12026694523093e-12 9 0 0 20 5310 WP2942 DDX1 as a regulatory component of the Drosha microprocessor 0.99999999999488 -5.12026694523093e-12 9 0 0 20 5310 WP3674 Tgif disruption of Shh signaling 0.99999999999488 -5.12026694523093e-12 9 0 0 20 5310 WP561 Heme Biosynthesis 0.99999999999488 -5.12026694523093e-12 9 0 0 20 5310 WP3297 EV release from cardiac cells and their functional effects 0.99999999999488 -5.12026694523093e-12 9 0 0 20 5310 WP696 Benzo(a)pyrene metabolism 0.99999999999488 -5.12026694523093e-12 9 0 0 20 5310 WP3585 Cytosine methylation 0.99999999999488 -5.12026694523093e-12 9 0 0 20 5310 WP3300 Dual hijack model of Vif in HIV infection 0.99999999999488 -5.12026694523093e-12 9 0 0 20 5310 WP1530 miRNA Regulation of DNA Damage Response 0.999999999994957 -5.04282044750482e-12 93 0 0 20 5310 WP554 ACE Inhibitor Pathway 0.999999999995235 -4.76486546314181e-12 17 0 0 20 5310 WP368 Mitochondrial LC-Fatty Acid Beta-Oxidation 0.999999999995235 -4.76486546314181e-12 17 0 0 20 5310 WP2916 Interactome of polycomb repressive complex 2 (PRC2) 0.999999999995235 -4.76486546314181e-12 17 0 0 20 5310 WP3678 Amplification and Expansion of Oncogenic Pathways as Metastatic Traits 0.999999999995235 -4.76486546314181e-12 17 0 0 20 5310 WP78 TCA Cycle 0.999999999995235 -4.76486546314181e-12 17 0 0 20 5310 WP3874 Canonical and Non-Canonical TGF-B signaling 0.999999999995235 -4.76486546314181e-12 17 0 0 20 5310 WP2289 Drug Induction of Bile Acid Pathway 0.999999999995235 -4.76486546314181e-12 17 0 0 20 5310 WP716 Vitamin A and Carotenoid Metabolism 0.999999999995237 -4.7629106082321e-12 44 0 0 20 5310 WP2332 Interleukin-11 Signaling Pathway 0.999999999995237 -4.7629106082321e-12 44 0 0 20 5310 WP314 Fas Ligand (FasL) pathway and Stress induction of Heat Shock Proteins (HSP) regulation 0.999999999995237 -4.7629106082321e-12 44 0 0 20 5310 WP2586 Aryl Hydrocarbon Receptor 0.999999999995299 -4.7008488426229e-12 48 0 0 20 5310 WP2873 Aryl Hydrocarbon Receptor Pathway 0.999999999995299 -4.7008488426229e-12 48 0 0 20 5310 WP2848 Differentiation Pathway 0.999999999995299 -4.7008488426229e-12 48 0 0 20 5310 WP2849 Hematopoietic Stem Cell Differentiation 0.999999999995299 -4.7008488426229e-12 48 0 0 20 5310 WP254 Apoptosis 0.999999999995309 -4.69101040313737e-12 86 0 0 20 5310 WP474 Endochondral Ossification 0.999999999995371 -4.62938521507077e-12 65 0 0 20 5310 WP3845 Canonical and Non-canonical Notch signaling 0.999999999996178 -3.82227317943958e-12 27 0 0 20 5310 WP143 Fatty Acid Beta Oxidation 0.999999999996251 -3.74947587025421e-12 34 0 0 20 5310 WP1601 Fluoropyrimidine Activity 0.999999999996251 -3.74947587025421e-12 34 0 0 20 5310 WP400 p38 MAPK Signaling Pathway 0.999999999996251 -3.74947587025421e-12 34 0 0 20 5310 WP2361 Gastric Cancer Network 1 0.999999999996455 -3.54478630205867e-12 28 0 0 20 5310 WP2249 Metastatic brain tumor 0.999999999996455 -3.54478630205867e-12 28 0 0 20 5310 WP1531 Vitamin D Metabolism 0.999999999996533 -3.46667408273785e-12 10 0 0 20 5310 WP3601 Composition of Lipid Particles 0.999999999996533 -3.46667408273785e-12 10 0 0 20 5310 WP496 Steroid Biosynthesis 0.999999999996533 -3.46667408273785e-12 10 0 0 20 5310 WP2874 Liver X Receptor Pathway 0.999999999996533 -3.46667408273785e-12 10 0 0 20 5310 WP2113 Type III interferon signaling 0.999999999996533 -3.46667408273785e-12 10 0 0 20 5310 WP2333 Trans-sulfuration pathway 0.999999999996533 -3.46667408273785e-12 10 0 0 20 5310 WP3656 Interleukin-1 Induced Activation of NF-kappa-B 0.999999999996533 -3.46667408273785e-12 10 0 0 20 5310 WP704 Methylation Pathways 0.999999999996533 -3.46667408273785e-12 10 0 0 20 5310 WP2406 Cardiac Progenitor Differentiation 0.99999999999675 -3.2501419976747e-12 53 0 0 20 5310 WP1533 Vitamin B12 Metabolism 0.99999999999675 -3.2501419976747e-12 53 0 0 20 5310 WP107 Translation Factors 0.99999999999675 -3.2501419976747e-12 53 0 0 20 5310 WP363 Wnt Signaling Pathway Netpath 0.99999999999675 -3.2501419976747e-12 53 0 0 20 5310 WP2371 Parkinsons Disease Pathway 0.999999999996824 -3.17599929783313e-12 83 0 0 20 5310 WP236 Adipogenesis 0.999999999996833 -3.16666865509034e-12 131 0 0 20 5310 WP179 Cell Cycle 0.999999999997765 -2.23527612226867e-12 105 0 0 20 5310 WP45 G1 to S cell cycle control 0.999999999997931 -2.06887703585276e-12 68 0 0 20 5310 WP3680 Association Between Physico-Chemical Features and Toxicity Associated Pathways 0.999999999997931 -2.06887703585276e-12 68 0 0 20 5310 WP2032 Human Thyroid Stimulating Hormone (TSH) signaling pathway 0.999999999997931 -2.06887703585276e-12 68 0 0 20 5310 WP3303 Rac1/Pak1/p38/MMP-2 pathway 0.999999999997931 -2.06887703585276e-12 68 0 0 20 5310 WP558 Complement and Coagulation Cascades 0.999999999997945 -2.05535954810354e-12 60 0 0 20 5310 WP3527 Preimplantation Embryo 0.999999999997945 -2.05535954810354e-12 60 0 0 20 5310 WP1 Statin Pathway 0.999999999997999 -2.00073464740047e-12 1 0 0 20 5310 WP661 Glucose Homeostasis 0.999999999997999 -2.00073464740047e-12 1 0 0 20 5310 WP2190 One carbon donor 0.999999999997999 -2.00073464740047e-12 1 0 0 20 5310 WP188 Focal Adhesion 0.999999999997999 -2.00073464740047e-12 1 0 0 20 5310 WP108 Selenium metabolism/Selenoproteins 0.999999999997999 -2.00073464740047e-12 1 0 0 20 5310 WP3191 TSLP Signaling Pathway 0.999999999997999 -2.00073464740047e-12 1 0 0 20 5310 WP3627 Gut-Liver Indole Metabolism 0.999999999997999 -2.00073464740047e-12 1 0 0 20 5310 WP2536 Colchicine Metabolic Pathway 0.999999999997999 -2.00073464740047e-12 1 0 0 20 5310 WP2267 Synaptic Vesicle Pathway 0.99999999999807 -1.930170155544e-12 52 0 0 20 5310 WP262 EBV LMP1 signaling 0.999999999998124 -1.87619227741896e-12 24 0 0 20 5310 WP334 GPCRs, Class B Secretin-like 0.999999999998124 -1.87619227741896e-12 24 0 0 20 5310 WP1539 Angiogenesis 0.999999999998124 -1.87619227741896e-12 24 0 0 20 5310 WP3658 Wnt/beta-catenin Signaling Pathway in Leukemia 0.999999999998124 -1.87619227741896e-12 24 0 0 20 5310 WP3925 Amino Acid metabolism 0.9999999999988 -1.19996806229415e-12 91 0 0 20 5310 WP3657 Hematopoietic Stem Cell Gene Regulation by GABP alpha/beta Complex 0.999999999998928 -1.07202161448949e-12 22 0 0 20 5310 WP100 Glutathione metabolism 0.999999999998928 -1.07202161448949e-12 22 0 0 20 5310 WP545 Complement Activation 0.999999999998928 -1.07202161448949e-12 22 0 0 20 5310 WP1424 Globo Sphingolipid Metabolism 0.999999999998928 -1.07202161448949e-12 22 0 0 20 5310 WP1584 Type II diabetes mellitus 0.999999999998928 -1.07202161448949e-12 22 0 0 20 5310 WP272 Blood Clotting Cascade 0.999999999998928 -1.07202161448949e-12 22 0 0 20 5310 WP3645 NAD+ biosynthetic pathways 0.999999999998928 -1.07202161448949e-12 22 0 0 20 5310 WP3599 Transcription factor regulation in adipogenesis 0.999999999998928 -1.07202161448949e-12 22 0 0 20 5310 WP167 Eicosanoid Synthesis 0.999999999998928 -1.07202161448949e-12 22 0 0 20 5310 WP3872 Regulation of Apoptosis by Parathyroid Hormone-related Protein 0.999999999998928 -1.07202161448949e-12 22 0 0 20 5310 WP2112 IL17 signaling pathway 0.999999999998967 -1.0333828174216e-12 31 0 0 20 5310 WP408 Oxidative Stress 0.999999999998967 -1.0333828174216e-12 31 0 0 20 5310 WP3850 Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling 0.999999999998967 -1.0333828174216e-12 31 0 0 20 5310 WP3849 MAPK and NFkB Signalling Pathways Inhibited by Yersinia YopJ 0.999999999999294 -7.05630986045081e-13 12 0 0 20 5310 WP2007 Iron metabolism in placenta 0.999999999999294 -7.05630986045081e-13 12 0 0 20 5310 WP3672 LncRNA-mediated mechanisms of therapeutic resistance 0.999999999999294 -7.05630986045081e-13 12 0 0 20 5310 WP2290 RalA downstream regulated genes 0.999999999999294 -7.05630986045081e-13 12 0 0 20 5310 WP1559 TFs Regulate miRNAs related to cardiac hypertrophy 0.999999999999294 -7.05630986045081e-13 12 0 0 20 5310 WP3301 MFAP5-mediated ovarian cancer cell motility and invasiveness 0.999999999999294 -7.05630986045081e-13 12 0 0 20 5310 WP106 Alanine and aspartate metabolism 0.999999999999294 -7.05630986045081e-13 12 0 0 20 5310 WP1425 Bone Morphogenic Protein (BMP) Signalling and Regulation 0.999999999999294 -7.05630986045081e-13 12 0 0 20 5310 WP2374 Oncostatin M Signaling Pathway 0.999999999999412 -5.87490251148105e-13 66 0 0 20 5310 WP3651 Pathways Affected in Adenoid Cystic Carcinoma 0.999999999999412 -5.87490251148105e-13 66 0 0 20 5310 WP2324 AGE/RAGE pathway 0.999999999999412 -5.87490251148105e-13 66 0 0 20 5310 WP183 Proteasome Degradation 0.999999999999412 -5.87490251148105e-13 66 0 0 20 5310 WP1433 Nucleotide-binding Oligomerization Domain (NOD) pathway 0.999999999999468 -5.31725348455612e-13 41 0 0 20 5310 WP382 MAPK Signaling Pathway 0.999999999999478 -5.21554432847378e-13 170 0 0 20 5310 WP2533 Glycerophospholipid Biosynthetic Pathway 0.999999999999753 -2.470565639584e-13 21 0 0 20 5310 WP3670 Simplified Interaction Map Between LOXL4 and Oxidative Stress Pathway 0.999999999999753 -2.470565639584e-13 21 0 0 20 5310 WP2507 Nanomaterial induced apoptosis 0.999999999999753 -2.470565639584e-13 21 0 0 20 5310 WP691 Tamoxifen metabolism 0.999999999999753 -2.470565639584e-13 21 0 0 20 5310 WP1602 Nicotine Activity on Dopaminergic Neurons 0.999999999999753 -2.470565639584e-13 21 0 0 20 5310 WP3286 Copper homeostasis 1.00000000000008 7.75578765849092e-14 54 0 0 20 5310 WP623 Oxidative phosphorylation 1.00000000000008 7.75578765849092e-14 54 0 0 20 5310 WP712 Estrogen signaling pathway 1.00000000000021 2.10247441893604e-13 23 0 0 20 5310 WP3612 Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling 1.00000000000021 2.10247441893604e-13 23 0 0 20 5310 WP3624 Lung fibrosis 1.00000000000034 3.44077919757267e-13 63 0 0 20 5310 WP43 Oxidation by Cytochrome P450 1.00000000000034 3.44077919757267e-13 63 0 0 20 5310 WP2431 Spinal Cord Injury 1.00000000000044 4.42306544245164e-13 119 0 0 20 5310 WP2884 NRF2 pathway 1.0000000000005 5.03471231401877e-13 143 0 0 20 5310 WP524 G13 Signaling Pathway 1.00000000000074 7.42335208746298e-13 40 0 0 20 5310 WP2516 ATM Signaling Pathway 1.00000000000074 7.42335208746298e-13 40 0 0 20 5310 WP111 Electron Transport Chain 1.00000000000096 9.63929459120743e-13 92 0 0 20 5310 WP170 Nuclear Receptors 1.00000000000098 9.78319046865386e-13 39 0 0 20 5310 WP2911 miRNA targets in ECM and membrane receptors 1.00000000000099 9.88472633304839e-13 43 0 0 20 5310 WP1971 Integrated Cancer Pathway 1.00000000000105 1.04760012974779e-12 46 0 0 20 5310 WP3878 ATM Signaling Network in Development and Disease 1.00000000000105 1.04760012974779e-12 46 0 0 20 5310 WP465 Tryptophan metabolism 1.00000000000105 1.04760012974779e-12 46 0 0 20 5310 WP28 Selenium Metabolism and Selenoproteins 1.00000000000105 1.04760012974779e-12 46 0 0 20 5310 WP268 Notch Signaling Pathway 1.00000000000105 1.04760012974779e-12 46 0 0 20 5310 WP1591 Heart Development 1.00000000000105 1.04760012974779e-12 46 0 0 20 5310 WP2118 Arrhythmogenic Right Ventricular Cardiomyopathy 1.00000000000126 1.25830626692823e-12 76 0 0 20 5310 WP1982 Sterol Regulatory Element-Binding Proteins (SREBP) signalling 1.00000000000178 1.77873699437521e-12 73 0 0 20 5310 WP24 Peptide GPCRs 1.00000000000215 2.1498545175922e-12 74 0 0 20 5310 WP2572 Primary Focal Segmental Glomerulosclerosis FSGS 1.00000000000215 2.1498545175922e-12 74 0 0 20 5310 WP299 Nuclear Receptors in Lipid Metabolism and Toxicity 1.0000000000026 2.60242065958585e-12 35 0 0 20 5310 WP3617 Photodynamic therapy-induced NF-kB survival signaling 1.0000000000026 2.60242065958585e-12 35 0 0 20 5310 WP2377 Integrated Pancreatic Cancer Pathway 1.00000000000264 2.64051754685626e-12 197 0 0 20 5310 WP1273 Folic Acid Network 1.00000000000277 2.76883537765041e-12 2 0 0 20 5310 WP2866 mir34a and TGIF2 in osteoclastogenesis 1.00000000000277 2.76883537765041e-12 2 0 0 20 5310 WP2901 Gonadotropin-releasing hormone (GnRH) signaling 1.00000000000277 2.76883537765041e-12 2 0 0 20 5310 WP2943 Hypoxia-mediated EMT and Stemness 1.00000000000277 2.76883537765041e-12 2 0 0 20 5310 WP2366 Butyrate-induced histone acetylation 1.00000000000277 2.76883537765041e-12 2 0 0 20 5310 WP2816 Felbamate Metabolism 1.00000000000277 2.76883537765041e-12 2 0 0 20 5310 WP2646 Lidocaine metabolism 1.00000000000277 2.76883537765041e-12 2 0 0 20 5310 WP1438 Influenza A virus infection 1.00000000000277 2.76883537765041e-12 2 0 0 20 5310 WP1311 Folic Acid Network 1.00000000000277 2.76883537765041e-12 2 0 0 20 5310 WP322 Osteoblast Signaling 1.00000000000287 2.86630533407992e-12 14 0 0 20 5310 WP229 Irinotecan Pathway 1.00000000000287 2.86630533407992e-12 14 0 0 20 5310 WP3853 ERK Pathway in Huntington's Disease 1.00000000000287 2.86630533407992e-12 14 0 0 20 5310 WP2436 Dopamine metabolism 1.00000000000287 2.86630533407992e-12 14 0 0 20 5310 WP241 One Carbon Metabolism 1.0000000000031 3.10058256191637e-12 30 0 0 20 5310 WP129 Matrix Metalloproteinases 1.0000000000031 3.10058256191637e-12 30 0 0 20 5310 WP2870 Extracellular vesicle-mediated signaling in recipient cells 1.0000000000031 3.10058256191637e-12 30 0 0 20 5310 WP2855 Dopaminergic Neurogenesis 1.0000000000031 3.10058256191637e-12 30 0 0 20 5310 WP3851 TLR4 Signaling and Tolerance 1.0000000000031 3.10058256191637e-12 30 0 0 20 5310 WP1941 Peroxisomal beta-oxidation of tetracosanoyl-CoA 1.00000000000312 3.12092689162575e-12 4 0 0 20 5310 WP733 Serotonin Receptor 2 and STAT3 Signaling 1.00000000000312 3.12092689162575e-12 4 0 0 20 5310 WP2253 Pilocytic astrocytoma 1.00000000000312 3.12092689162575e-12 4 0 0 20 5310 WP690 Polyol Pathway 1.00000000000312 3.12092689162575e-12 4 0 0 20 5310 WP521 Amino acid conjugation of benzoic acid 1.00000000000312 3.12092689162575e-12 4 0 0 20 5310 WP2889 Oxytocin signaling 1.00000000000312 3.12092689162575e-12 4 0 0 20 5310 WP1133 Androgen receptor signaling pathway 1.00000000000312 3.12092689162575e-12 4 0 0 20 5310 WP897 Androgen receptor signaling pathway 1.00000000000312 3.12092689162575e-12 4 0 0 20 5310 WP1603 Nicotine Activity on Chromaffin Cells 1.00000000000312 3.12092689162575e-12 4 0 0 20 5310 WP2491 Diclofenac Metabolic Pathway 1.00000000000312 3.12092689162575e-12 4 0 0 20 5310 WP3633 Caffeine and Theobromine metabolism 1.00000000000312 3.12092689162575e-12 4 0 0 20 5310 WP3302 eIF5A regulation in response to inhibition of the nuclear export system 1.00000000000312 3.12092689162575e-12 4 0 0 20 5310 WP2828 Bladder Cancer 1.0000000000034 3.39551452393334e-12 32 0 0 20 5310 WP3858 Toll-like Receptor Signaling 1.0000000000034 3.39551452393334e-12 32 0 0 20 5310 WP34 Ovarian Infertility Genes 1.0000000000034 3.39551452393334e-12 32 0 0 20 5310 WP727 Monoamine Transport 1.0000000000034 3.39551452393334e-12 32 0 0 20 5310 WP3893 Development and heterogeneity of the ILC family 1.0000000000034 3.39551452393334e-12 32 0 0 20 5310 WP2525 Trans-sulfuration and one carbon metabolism 1.0000000000034 3.39551452393334e-12 32 0 0 20 5310 WP2875 Constitutive Androstane Receptor Pathway 1.0000000000034 3.39551452393334e-12 32 0 0 20 5310 WP411 mRNA Processing 1.00000000000346 3.46060541769231e-12 132 0 0 20 5310 WP3915 Angiopoietin Like Protein 8 Regulatory Pathway 1.00000000000346 3.46060541769231e-12 132 0 0 20 5310 WP1772 Apoptosis Modulation and Signaling 1.00000000000373 3.73134328048504e-12 94 0 0 20 5310 WP231 TNF alpha Signaling Pathway 1.00000000000373 3.73134328048504e-12 94 0 0 20 5310 WP197 Cholesterol Biosynthesis 1.00000000000387 3.86726675767466e-12 15 0 0 20 5310 WP206 Fatty Acid Omega Oxidation 1.00000000000387 3.86726675767466e-12 15 0 0 20 5310 WP3 Transcriptional activation by NRF2 1.00000000000387 3.86726675767466e-12 15 0 0 20 5310 WP2435 Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis 1.00000000000387 3.86726675767466e-12 15 0 0 20 5310 WP453 Inflammatory Response Pathway 1.00000000000419 4.191004070978e-12 33 0 0 20 5310 WP430 Statin Pathway 1.00000000000419 4.191004070978e-12 33 0 0 20 5310 WP58 Monoamine GPCRs 1.00000000000419 4.191004070978e-12 33 0 0 20 5310 WP2363 Gastric Cancer Network 2 1.00000000000419 4.191004070978e-12 33 0 0 20 5310 WP2064 Neural Crest Differentiation 1.0000000000045 4.50405739529913e-12 102 0 0 20 5310 WP1544 MicroRNAs in cardiomyocyte hypertrophy 1.0000000000045 4.50405739529913e-12 102 0 0 20 5310 WP399 Wnt Signaling Pathway and Pluripotency 1.00000000000507 5.06726344994742e-12 106 0 0 20 5310 WP1545 miRNAs involved in DNA damage response 1.00000000000515 5.15029885672328e-12 50 0 0 20 5310 WP2637 Structural Pathway of Interleukin 1 (IL-1) 1.00000000000515 5.15029885672328e-12 50 0 0 20 5310 WP205 IL-7 Signaling Pathway 1.00000000000519 5.19102537015644e-12 25 0 0 20 5310 WP2865 IL1 and megakaryocytes in obesity 1.00000000000519 5.19102537015644e-12 25 0 0 20 5310 WP3668 Hypothesized Pathways in Pathogenesis of Cardiovascular Disease 1.00000000000519 5.19102537015644e-12 25 0 0 20 5310 WP1528 Physiological and Pathological Hypertrophy of the Heart 1.00000000000519 5.19102537015644e-12 25 0 0 20 5310 WP2895 Differentiation of white and brown adipocyte 1.00000000000519 5.19102537015644e-12 25 0 0 20 5310 WP117 GPCRs, Other 1.00000000000545 5.44799324560715e-12 95 0 0 20 5310 WP702 Metapathway biotransformation 1.00000000000599 5.99229671311949e-12 177 0 0 20 5310 WP3594 Circadian rythm related genes 1.00000000000615 6.15203505316349e-12 207 0 0 20 5310 WP61 Notch Signaling Pathway 1.00000000000688 6.88245009264721e-12 62 0 0 20 5310 WP694 Arylamine metabolism 1.00000000000694 6.94432904997878e-12 6 0 0 20 5310 WP1981 Thyroxine (Thyroid Hormone) Production 1.00000000000694 6.94432904997878e-12 6 0 0 20 5310 WP1600 Nicotine Metabolism 1.00000000000694 6.94432904997878e-12 6 0 0 20 5310 WP3891 Benzene metabolism 1.00000000000694 6.94432904997878e-12 6 0 0 20 5310 WP1455 Serotonin Transporter Activity 1.00000000000743 7.42994033854492e-12 11 0 0 20 5310 WP2854 Gene regulatory network modelling somitogenesis 1.00000000000743 7.42994033854492e-12 11 0 0 20 5310 WP2513 Nanoparticle triggered regulated necrosis 1.00000000000743 7.42994033854492e-12 11 0 0 20 5310 WP80 Nucleotide GPCRs 1.00000000000743 7.42994033854492e-12 11 0 0 20 5310 WP3630 NAD metabolism, sirtuins and aging 1.00000000000743 7.42994033854492e-12 11 0 0 20 5310 WP3611 Photodynamic therapy-induced AP-1 survival signaling. 1.0000000000075 7.5015542880837e-12 51 0 0 20 5310 WP3646 Hepatitis C and Hepatocellular Carcinoma 1.0000000000075 7.5015542880837e-12 51 0 0 20 5310 WP706 Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways 1.0000000000076 7.59557640650611e-12 162 0 0 20 5310 WP134 Pentose Phosphate Pathway 1.00000000000782 7.82405686809616e-12 7 0 0 20 5310 WP1272 Selenium Micronutrient Network 1.00000000000782 7.82405686809616e-12 7 0 0 20 5310 WP678 Arachidonate Epoxygenase / Epoxide Hydrolase 1.00000000000782 7.82405686809616e-12 7 0 0 20 5310 WP2596 Gastric acid production 1.00000000000782 7.82405686809616e-12 7 0 0 20 5310 WP3924 Hfe effect on hepcidin production 1.00000000000782 7.82405686809616e-12 7 0 0 20 5310 WP699 Aflatoxin B1 metabolism 1.00000000000782 7.82405686809616e-12 7 0 0 20 5310 WP2805 RNA interference 1.00000000000782 7.82405686809616e-12 7 0 0 20 5310 WP1995 Effects of Nitric Oxide 1.00000000000782 7.82405686809616e-12 7 0 0 20 5310 WP3595 mir-124 predicted interactions with cell cycle and differentiation 1.00000000000782 7.82405686809616e-12 7 0 0 20 5310 WP1310 Selenium Micronutrient Network 1.00000000000782 7.82405686809616e-12 7 0 0 20 5310 WP438 Non-homologous end joining 1.00000000000782 7.82405686809616e-12 7 0 0 20 5310 WP528 Acetylcholine Synthesis 1.00000000000782 7.82405686809616e-12 7 0 0 20 5310 WP3865 RIG-I-like Receptor Signaling 1.00000000000805 8.0517156308721e-12 61 0 0 20 5310 WP2446 Retinoblastoma (RB) in Cancer 1.00000000000824 8.24190506486952e-12 88 0 0 20 5310 WP15 Selenium Micronutrient Network 1.0000000000085 8.49589232265349e-12 87 0 0 20 5310 WP410 Diurnally Regulated Genes with Circadian Orthologs 1.00000000000892 8.91552691509988e-12 49 0 0 20 5310 WP534 Glycolysis and Gluconeogenesis 1.00000000000892 8.91552691509988e-12 49 0 0 20 5310 WP619 Type II interferon signaling (IFNG) 1.0000000000093 9.3029338794218e-12 37 0 0 20 5310 WP3529 Zinc homeostasis 1.0000000000093 9.3029338794218e-12 37 0 0 20 5310 WP1471 Target Of Rapamycin (TOR) Signaling 1.0000000000093 9.3029338794218e-12 37 0 0 20 5310 WP3614 Photodynamic therapy-induced HIF-1 survival signaling 1.0000000000093 9.3029338794218e-12 37 0 0 20 5310 WP3414 Initiation of transcription and translation elongation at the HIV-1 LTR 1.0000000000093 9.3029338794218e-12 37 0 0 20 5310 WP75 Toll-like Receptor Signaling Pathway 1.00000000000934 9.33794942416395e-12 103 0 0 20 5310 WP3879 4-hydroxytamoxifen, Dexamethasone, and Retinoic Acids Regulation of p27 Expression 1.0000000000099 9.89536114111341e-12 18 0 0 20 5310 WP3859 TGF-B Signaling in Thyroid Cells for Epithelial-Mesenchymal Transition 1.0000000000099 9.89536114111341e-12 18 0 0 20 5310 WP3664 Regulation of Wnt/B-catenin Signaling by Small Molecule Compounds 1.0000000000099 9.89536114111341e-12 18 0 0 20 5310 WP692 Sulfation Biotransformation Reaction 1.0000000000099 9.89536114111341e-12 18 0 0 20 5310 WP3413 NOTCH1 regulation of human endothelial cell calcification 1.0000000000099 9.89536114111341e-12 18 0 0 20 5310 WP1984 Integrated Breast Cancer Pathway 1.00000000001054 1.05383265833024e-11 154 0 0 20 5310 WP501 GPCRs, Class C Metabotropic glutamate, pheromone 1.00000000001157 1.15695850260703e-11 16 0 0 20 5310 WP2291 Deregulation of Rab and Rab Effector Genes in Bladder Cancer 1.00000000001157 1.15695850260703e-11 16 0 0 20 5310 WP550 Biogenic Amine Synthesis 1.00000000001157 1.15695850260703e-11 16 0 0 20 5310 WP3644 NAD+ metabolism 1.00000000001157 1.15695850260703e-11 16 0 0 20 5310 WP47 Hedgehog Signaling Pathway 1.00000000001157 1.15695850260703e-11 16 0 0 20 5310 WP2453 TCA Cycle and Deficiency of Pyruvate Dehydrogenase complex (PDHc) 1.00000000001157 1.15695850260703e-11 16 0 0 20 5310 WP53 ID signaling pathway 1.00000000001157 1.15695850260703e-11 16 0 0 20 5310 WP1946 Cori Cycle 1.00000000001157 1.15695850260703e-11 16 0 0 20 5310